{
    "name": "polidocanol",
    "comment": "Rx",
    "other_names": [
        "Asclera",
        "Varithena"
    ],
    "classes": [
        "Sclerosing Agents"
    ],
    "source": "https://reference.medscape.com/drug/asclera-varithena-polidocanol-999494",
    "pregnancy": {
        "common": [
            "There are no adequate and well-controlled studies in pregnant women",
            "Few published case reports with use of polidocanol-containing products, in pregnant women have not identified any drug-associated risk for major birth defects, miscarriage, or adverse maternal or fetal outcomes; although no risks identified, there is minimal benefit in treating lower extremity varicosities during pregnancy and lower extremity varicosities that develop during pregnancy as they may spontaneously regress postpartum",
            "Polidocanol reported to have an embryocidal effect in rabbits when given in doses approximately equal (on the basis of body surface area) to the human dose; this effect may have been secondary to maternal toxicity",
            "Developmental reproductive toxicity testing was performed in rats and rabbits with IV administration"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "There are no data on presence of polidocanol in human milk, effects on breastfed infant, or on milk production; a lactating woman may consider interrupting breastfeeding and pumping and discarding breast milk up to 8 hours after administration in order to minimize exposure to a breastfed infant"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [],
            "specific": []
        },
        "cautions": {
            "common": [],
            "specific": []
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Injection site hematoma",
            "percent": "42"
        },
        {
            "name": "Injection site irritation",
            "percent": "41"
        },
        {
            "name": "Injection site discoloration",
            "percent": "38"
        },
        {
            "name": "Injection site pain",
            "percent": "24"
        },
        {
            "name": "Injection site pruritus",
            "percent": "19"
        },
        {
            "name": "Injection site warmth",
            "percent": "16"
        },
        {
            "name": "Pain in extremity",
            "percent": "16.8"
        },
        {
            "name": "Infusion site thrombosis",
            "percent": "16.1"
        },
        {
            "name": "Contusion",
            "percent": "15.4"
        },
        {
            "name": "injection site hematoma",
            "percent": "12.1"
        },
        {
            "name": "Limb discomfort",
            "percent": "10.7"
        },
        {
            "name": "Injection site pain",
            "percent": "8"
        },
        {
            "name": "tenderness",
            "percent": "6"
        },
        {
            "name": "Neovascularization",
            "percent": "8.1"
        },
        {
            "name": "Injection site thrombosis",
            "percent": "5.4"
        },
        {
            "name": "Venous thrombosis limb",
            "percent": "4.7"
        },
        {
            "name": "Superficial thrombophlebitis",
            "percent": null
        },
        {
            "name": "Deep vein thrombosis",
            "percent": null
        }
    ]
}